3.9 Article

Computational ECG mapping and respiratory gating to optimize stereotactic ablative radiotherapy workflow for refractory ventricular tachycardia

期刊

HEART RHYTHM O2
卷 2, 期 5, 页码 511-520

出版社

ELSEVIER
DOI: 10.1016/j.hroo.2021.09.001

关键词

Ablation; Cardiac computed tomography; Electrocardiography; Noninvasive mapping; Stereotactic ablative radiotherapy; Ventricular tachycardia

向作者/读者索取更多资源

The study aims to investigate the role of automated ECG mapping and respiratory-gated therapy in SAbR treatment. Results demonstrate that this workflow can improve the ease and precision of treatment planning, and in some cases, help avoid gastrointestinal complications.
BACKGROUND Stereotactic ablative radiotherapy (SAbR) is an emerging therapy for refractory ventricular tachycardia (VT). However, the current workflow is complicated, and the precision and safety in patients with significant cardiorespiratory motion and VT targets near the stomach may be suboptimal. OBJECTIVE We hypothesized that automated 12-lead electrocardiogram (ECG) mapping and respiratory-gated therapy may improve the ease and precision of SAbR planning and facilitate safe radiation delivery in patients with refractory VT. METHODS Consecutive patients with refractory VT were studied at 2 hospitals. VT exit sites were localized using a 3-D computational ECG algorithm noninvasively and compared to available prior invasive mapping. Radiotherapy (25 Gy) was delivered at end-expiration when cardiac respiratory motion was >= 0.6 cm or targets were <= 2 cm from the stomach. RESULTS In 6 patients (ejection fraction 29% +/- 13%), 4.2 +/- 2.3 VT morphologies per patient were mapped. Overall, 7 out of 7 computational ECG mappings (100%) colocalized to the identical cardiac segment when prior invasive electrophysiology study was available. Respiratory gating was associated with smaller planning target volumes compared to nongated volumes (71 +/- 7 vs 153 +/- 35 cc, P < .01). In 2 patients with inferior wall VT targets close to the stomach (6 mm proximity) or significant respiratory motion (22 mm excursion), no GI complications were observed at 9- and 12-month follow-up. Implantable cardioverter-defibrillator shocks decreased from 23 +/- 12 shocks/patient to 0.67 +/- 1.0 (P < .001) post-SAbR at 6.0 +/- 4.9 months follow-up. CONCLUSIONS A workflow including computational ECG mapping and protocol-guided respiratory gating is feasible, is safe, and may improve the ease of SAbR planning. Studies to validate this workflow in larger populations are required.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.9
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据